Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Hartmann

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Cancer|December 1, 1994
Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocolL C Hartmann, J N Ingle, L E Wold, et al.
Human Mutation|June 30, 2000
Genetic heterogeneity in Peutz-Jeghers syndromeL A Boardman, F J Couch, L J Burgart, et al.
Cancer|January 5, 2000
A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinomaE A Perez, D W Hillman, P J Stella, et al.
JAMA|October 12, 2000
Risk of breast cancer with oral contraceptive use in women with a family history of breast cancerD M Grabrick, L C Hartmann, J R Cerhan, et al.
Medicine|October 20, 2000
Association of Peutz-Jeghers-like mucocutaneous pigmentation with breast and gynecologic carcinomas in womenL A Boardman, M R Pittelkow, F J Couch, et al.
Cancer|April 3, 1999
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinomaJ N Ingle, V J Suman, C G Kardinal, et al.
The New England Journal of Medicine|June 19, 1997
Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropeniaL C Hartmann, L K Tschetter, T M Habermann, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|August 15, 2001
A randomized trial of interferon-alpha in cervical dysplasiaB S Gostout, L C Hartmann, V J Suman, et al.
The New England Journal of Medicine|January 14, 1999
Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancerL C Hartmann, D J Schaid, J E Woods, et al.
Investigational New Drugs|November 9, 2014
A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumorsP P Peethambaram, L C Hartmann, D J Jonker, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Cancer|December 1, 1994
Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocolL C Hartmann, J N Ingle, L E Wold, et al.
Human Mutation|June 30, 2000
Genetic heterogeneity in Peutz-Jeghers syndromeL A Boardman, F J Couch, L J Burgart, et al.
Cancer|January 5, 2000
A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinomaE A Perez, D W Hillman, P J Stella, et al.
JAMA|October 12, 2000
Risk of breast cancer with oral contraceptive use in women with a family history of breast cancerD M Grabrick, L C Hartmann, J R Cerhan, et al.
Medicine|October 20, 2000
Association of Peutz-Jeghers-like mucocutaneous pigmentation with breast and gynecologic carcinomas in womenL A Boardman, M R Pittelkow, F J Couch, et al.
Cancer|April 3, 1999
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinomaJ N Ingle, V J Suman, C G Kardinal, et al.
The New England Journal of Medicine|June 19, 1997
Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropeniaL C Hartmann, L K Tschetter, T M Habermann, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|August 15, 2001
A randomized trial of interferon-alpha in cervical dysplasiaB S Gostout, L C Hartmann, V J Suman, et al.
The New England Journal of Medicine|January 14, 1999
Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancerL C Hartmann, D J Schaid, J E Woods, et al.
Investigational New Drugs|November 9, 2014
A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumorsP P Peethambaram, L C Hartmann, D J Jonker, et al.
Pageof 7